Medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances

A technology for amphetamines and dependence disorders, applied in the field of medical drugs, can solve problems such as abuse, lack of simultaneous treatment, and unsatisfactory drug efficacy, and achieve the effect of controlling withdrawal symptoms

Inactive Publication Date: 2014-01-08
卢正堂 +1
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are some therapeutic drugs on the market, but the curative effect is not satisfactory, and all of them can only treat the dependence of a certain substance of abuse
However, the problem of multi-drug or multi-substance abuse is common. For example, in my country, in recent years, mixed dependence on amphetamine-type stimulants and opioids is often seen in clinics. drugs, that is, opioid-free drugs that are suboptimal for the monotherapy of amphetamine-type stimulants or opioid dependence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances
  • Medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances
  • Medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] The percentage by weight of the drug components is: 92% olanzapine, 3% chloracetamide, 5% diphenhydramine, after mixing auxiliary materials such as starch and talcum powder with the above-mentioned drug raw materials, the method is prepared according to the prior art Into capsules (200 mg per capsule).

Embodiment 2

[0080] The weight percent of medicine component is: 85% mirtazapine, 2% lofexidine, 5% scopolamine, 8% flunitrazepam, after auxiliary materials such as starch, talcum powder are mixed with above-mentioned medicine raw material, according to prior art The method is made into tablets (200 mg per tablet).

Embodiment 3

[0082] The weight percentage of the drug components: 90% aripiprazole, 5% clofenoxaline, 5% trihexyphenidyl, made by mixing the auxiliary materials such as starch and talcum powder with the above-mentioned drug raw materials according to the method of the prior art Capsules (200 mg each).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances. The medicament is prepared from the following components by weight percent: 2-95% of antipsychotics, 0.001-5% of alpha2 adrenergic agonists, 0-5% of anticholinergic agent, 0-80% of nonopioid analgesic, and 0-10% of benzodiazepine. The pharmaceutical composition disclosed by the invention achieves an ideal effect when the symptoms of a sufferer abusing stimulants such as benzedrine, or abusing the opiates substances in a merging manner are treated; the withdrawal symptom can be rapidly and obviously controlled; the detoxification recovery rate can be up to over 90%.

Description

[0001] This application is a divisional case of the invention patent application with application number 201010170021.X and titled "Medication for Treating Amphetamine-type Stimulant Dependence and Mixed Dependence with Opioids", and the filing date of the original case is May 12, 2010 . technical field [0002] The invention relates to the technical field of medical medicines, in particular to a combined drug for treating amphetamine-type stimulant dependence, amphetamine-type stimulant and opioid mixed dependence. Background technique [0003] At present, the problem of drug abuse is relatively serious. The abused substances include: amphetamine and other stimulants (commonly known as: methamphetamine, ecstasy, K powder, etc.), opioid substances (such as: morphine, heroin, opium tincture, opium, etc.) and so on. There are some therapeutic drugs on the market, but the curative effect is not satisfactory, and all of them can only treat dependence on a certain substance of ab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/5513A61K31/5517A61P25/36A61P25/30
Inventor 卢正堂张荣
Owner 卢正堂
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap